z-logo
open-access-imgOpen Access
AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
Author(s) -
R Govind Reddy,
Rajesh V. Gosavi,
Babita Yadav,
Amit Kumar,
Madhuri Holay,
Manisha Talekar,
Sophia Jameela,
Bhagwan Sahai Sharma,
Shruti Khanduri,
Rakesh Rana,
Arunabh Tripathi,
Bhogavalli Chandrasekhararao,
Narayanam Srikanth,
Kartar Singh Dhiman
Publication year - 2020
Publication title -
ayu
Language(s) - English
Resource type - Journals
eISSN - 0976-9382
pISSN - 0974-8520
DOI - 10.4103/ayu.ayu_14_21
Subject(s) - medicine , asymptomatic , randomized controlled trial , adverse effect , covid-19 , clinical trial , disease , infectious disease (medical specialty)
The evidence on the efficacy and safety of Ayurveda interventions as an add-on to the standard conventional care for coronavirus disease-2019 (COVID-19) is limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here